Quality of life in the GLARIUS trial randomizing bevacizumab/irinotecan versus temozolomide in newly diagnosed, MGMT-nonmethylated glioblastoma

Date Issued
2017
Author(s)
Schäfer, Niklas
Proescholdt, Martin
Steinbach, Joachim P
Weyerbrock, Astrid
Hau, Peter
Grauer, Oliver
Goldbrunner, Roland
Friedrich, Franziska
Ringel, Florian
Schlegel, Uwe
Sabel, Michael
Ronellenfitsch, Michael W
Uhl, Martin
Grau, Stefan
Hänel, Mathias
Schnell, Oliver
Krex, Dietmar
Vajkoczy, Peter
Tabatabai, Ghazaleh
Mack, Frederic
Schaub, Christina
Tzaridis, Theophilos
Nießen, Michael
Kebir, Sied
Leutgeb, Barbara
Urbach, Horst
Belka, Claus
Stummer, Walter
Glas, Martin
Herrlinger, Ulrich
DOI
10.1093/neuonc/nox204